Future of Crores in Maharashtra Hangs by a Thread as WHO’s Delay on Covaxin Approval Persists
The WHO has sought “additional clarifications” from Bharat Biotech for Covaxin to conduct a final risk-benefit assessment for Emergency Use Listing of the vaccine.